K2 HealthVentures Equity Trust LLC 13D and 13G filings for Elevation Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:45 pm Purchase | 2023-12-31 | 13G | Elevation Oncology, Inc. ELEV | K2 HealthVentures Equity Trust LLC | 1,784,169 4.000% | 217,705 (+13.90%) | Filing |
| 2022-09-30 5:24 pm Purchase | 2022-07-27 | 13G | Elevation Oncology, Inc. ELEV | K2 HealthVentures Equity Trust LLC | 1,566,464 6.300% | 1,566,464 (New Position) | Filing |